CoChat

Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases

Open access
Gubert, Fernanda, da Silva, Jaqueline Soares, Vasques, Juliana F., de Jesus Gonçalves, Renata Guedes, Martins, Robertta Silva, de Sá, Mauro Paes Leme, Mendez-Otero, Rosalia, Zapata-Sudo, Gisele · 2021 · International Journal of Molecular Sciences
Cited by 53

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Stem cell therapy is a promising alternative approach to heart diseases. The most prevalent source of multipotent stem cells, usually called somatic or adult stem cells (mesenchymal stromal/stem cells, MSCs) used in clinical trials is bone marrow (BM-MSCs), adipose tissue (AT-MSCs), umbilical cord (UC-MSCs) and placenta. Therapeutic use of MSCs in cardiovascular diseases is based on the benefits in reducing cardiac fibrosis and inflammation that compose the cardiac remodeling responsible for the maintenance of normal function, something which may end up causing progressive and irreversible dysfunction. Many factors lead to cardiac fibrosis and failure, and an effective therapy is lacking to reverse or attenuate this condition. Different approaches have been shown to be promising in surpassing the poor survival of transplanted cells in cardiac tissue to provide cardioprotection and prevent cardiac remodeling. This review includes the description of pre-clinical and clinical investigation of the therapeutic potential of MSCs in improving ventricular dysfunction consequent to diverse cardiac diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22147447

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 53

Metadata

Authors
Gubert, F., da Silva, J. S., Vasques, J. F., de Jesus Gonçalves, R. G., Martins, R. S., de Sá, M. P. L., Mendez-Otero, R., & Zapata-Sudo, G.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-07-12
Volume
22
Issue
14
Pages
7447
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3181397713
Cited by
53
References
6
FWCI
3.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases. https://app.cochat.ai/papers/10.3390/ijms22147447
The paper
Gubert, F., da Silva, J. S., Vasques, J. F., de Jesus Gonçalves, R. G., Martins, R. S., de Sá, M. P. L., Mendez-Otero, R., & Zapata-Sudo, G. (2021). Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22147447

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.